The Role of HbA1c in the Follow-Up and Control of Diabetes Mellitus

Soliman S Ghanem1, Eman M Abdulkreem2, Muath S Alfurayh3

  • 1Basic Sciences, College of Pharmacy, Rafha, SAU.

Cureus
|March 4, 2025
PubMed

Insights

Glycosylated hemoglobin (HbA1c) testing is crucial for diabetes management. Despite high awareness, many diabetic patients in Saudi Arabia have suboptimal follow-up practices, impacting blood sugar control and outcomes.

Area of Science:

  • Endocrinology
  • Clinical Chemistry
  • Public Health

Background:

  • Glycosylated hemoglobin (HbA1c) is vital for diagnosing and monitoring diabetes mellitus.
  • Comorbidities like kidney disease, anemia, and certain medications can affect HbA1c accuracy.
  • Effective diabetes management requires understanding HbA1c's role across diverse patient groups.

Purpose of the Study:

  • To evaluate the utility of HbA1c testing in managing diabetes mellitus.
  • To assess HbA1c's role in patient follow-up within Saudi Arabia.
  • To identify factors influencing HbA1c testing practices and outcomes.

Main Methods:

  • Quantitative study utilizing an online electronic questionnaire.
  • Questionnaire distributed in English and Arabic via Google Forms.
  • Data collected from 412 diabetic patients regarding HbA1c awareness and practice.

Main Results:

  • High awareness of HbA1c tests and their importance was observed.
  • A significant gap exists between awareness and regular testing practice; most patients tested less frequently than recommended.
  • A considerable percentage (35.7%) of patients with HbA1c levels above 10% took no action.
  • Average HbA1c levels among participants ranged between 7% and 10%.

Conclusions:

  • HbA1c testing remains a cornerstone for diabetes diagnosis and prognosis, improving patient care.
  • Regular HbA1c testing every three months is recommended for optimal diabetes control.
  • Healthcare providers and patients should not solely rely on post-prandial glucose levels, especially for insulin-dependent diabetics.

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
227
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
495
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
3.0K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
149